SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
155.60    2.80 (1.83%)
Bid:
155.40
Ask:
155.80
Spread: 0.40 (0.257%)
Market Cap: £890.52m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

AGM / Interim Management Statement

27 Apr 2016 07:00

ELEMENTIS PLC - AGM / Interim Management Statement

ELEMENTIS PLC - AGM / Interim Management Statement

PR Newswire

London, April 26

27 April 2016

AGM / Interim Management Statement

Elementis plc (ELM.L, the “Company" or the “Group"), the Global Specialty Chemicals Company, today issues its Interim Management Statement for the three months ended 31 March 2016.

Commenting on the Company’s performance Group Chief Executive, Paul Waterman, said: “During my first two months at Elementis I have been impressed by the quality of our people and the resilience of our business model. This is best exemplified by the sustained level of contribution margins in Specialty Products, the relative stability of the Chromium business in North America and the Group’s strong cash generation. Although some markets continue to be challenging and we are cycling against a stronger first quarter in 2015, we are proactively managing our margins and cost base to ensure that our performance for the year remains in line with management expectations.”

In Specialty Products, sales performance in coatings and personal care was satisfactory, while currency and lower oilfield sales resulted in total sales being 7 per cent below the same period last year. The following comments by division refer to constant currency sales:

In coatings additives, sales in North America were similar to the previous year as sales of decorative products from the New Martinsville plant continued to make good progress, while industrial sales remained subdued due to the impact of the stronger dollar on consumer exports, as previously reported. Sales in Europe were 1 per cent higher, while sales in Asia Pacific were 1 per cent lower, following the destocking and adjustment that took place in the Chinese economy in the second quarter of 2015. Sales to Latin America represent 5 per cent of total coatings sales and were 9 per cent lower than the previous year due to economic weakness in that region, particularly in Brazil.

In personal care, sales were 4 per cent higher than the previous period, as the business continued to benefit from geographic expansion and new product sales.

Sales in oilfield drilling were broadly in line with the quarterly sales run rate experienced in the second half of 2015, following the sharp downturn in North American demand that took place in the early part of 2015. Consequently, sales for the current quarter were 37 per cent below the same quarter last year.

As anticipated, Chromium sales for the first quarter were 11 per cent lower than the previous year, as market conditions outside of North America continued to be challenging. Although sales in North America were lower by 5 per cent, this is largely due to order timing and sales for the first six months of the year are expected to be in line with the same period last year. Sales outside of North America were 19 per cent lower than the previous year, with volumes lower by 6 per cent and pricing lower by 13 per cent.

The Group’s balance sheet remains strong and is again expected to be in a net cash position at the end of the year which, under our dividend policy, will continue to provide shareholders with attractive returns.

ENDS

Enquiries:

Elementis Paul Waterman, Chief Executive Brian Taylorson, Finance Director+ 44 (0) 207 067 2999
FTI Consulting Deborah Scott Matthew Cole+ 44 (0) 203 727 1000
Date   Source Headline
8th Jun 20265:14 pmRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSCommencement of share buyback programme
2nd Jun 20267:00 amRNSSale of Pharma business & intended buyback launch
1st Jun 20269:58 amRNSTotal Voting Rights
5th May 20265:26 pmRNSHolding(s) in Company
1st May 20269:59 amRNSTotal Voting Rights
29th Apr 20263:47 pmRNSResult of AGM
29th Apr 20267:00 amRNSFirst quarter trading update
8th Apr 20264:14 pmRNSDirector/PDMR Shareholding
7th Apr 20263:06 pmRNSDirector/PDMR Shareholding
1st Apr 202610:18 amRNSTotal Voting Rights
30th Mar 20265:06 pmRNSCorrection - Admission to Trading
30th Mar 20261:58 pmRNSAdmission to Trading
26th Mar 202612:09 pmRNSNotice of AGM and Annual Report & Accounts
19th Mar 20267:00 amRNSDirectorate change
11th Mar 20263:18 pmRNSDirector/PDMR Shareholding
11th Mar 20263:18 pmRNSDirector/PDMR Shareholding
10th Mar 20263:40 pmRNSDirector/PDMR Shareholding
10th Mar 20263:40 pmRNSDirector/PDMR Shareholding
10th Mar 20263:39 pmRNSDirector/PDMR Shareholding
9th Mar 20265:14 pmRNSHolding(s) in Company
5th Mar 20265:11 pmRNSBlocklisting Interim Review
5th Mar 20264:57 pmRNSPreliminary Results - Correction
5th Mar 20267:00 amRNSPreliminary Results
2nd Mar 202610:00 amRNSTotal Voting Rights
25th Feb 20264:22 pmRNSDirectorate change
2nd Feb 202610:05 amRNSTotal Voting Rights
21st Jan 20267:00 amRNSTrading Update
2nd Jan 202611:10 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSConfirmation of Board changes
2nd Jan 20267:00 amRNSConfirmation of Board changes
24th Dec 202510:25 amRNSDirector/PDMR Shareholding
24th Dec 202510:25 amRNSDirector/PDMR Shareholding
15th Dec 20257:00 amRNSCompletion of Buyback programme
15th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20255:35 pmRNSTransaction in Own Shares
10th Dec 20256:12 pmRNSTransaction in Own Shares
9th Dec 20255:55 pmRNSTransaction in Own Shares
8th Dec 20255:52 pmRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20256:06 pmRNSTransaction in Own Shares
3rd Dec 20255:28 pmRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20255:49 pmRNSTransaction in Own Shares
28th Nov 20255:49 pmRNSTransaction in Own Shares
27th Nov 20255:40 pmRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSElementis acquires personal care specialist
25th Nov 20255:44 pmRNSTransaction in Own Shares
24th Nov 20256:01 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.